Drug Shortage Report for DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP
Report ID | 171105 |
Drug Identification Number | 00761834 |
Brand name | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP |
Common or Proper name | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE DOPAMINE HYDROCHLORIDE |
Strength(s) | 50MG 3.2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 250mL |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-10-04 |
Actual start date | 2022-10-04 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-11-30 |
Shortage status | Resolved |
Updated date | 2022-12-01 |
Company comments | Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 200mg/250mL bags (DIN 00761850) are available as alternatives if they align with clinical practice. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-12-01 | English | Compare |
v5 | 2022-11-30 | French | Compare |
v4 | 2022-11-30 | English | Compare |
v3 | 2022-10-05 | English | Compare |
v2 | 2022-10-04 | French | Compare |
v1 | 2022-10-04 | English | Compare |
Showing 1 to 6 of 6